A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a new study finds.
"Patients with Medicare Part D have dozens of different drug plans available to choose from, but most patients unfortunately are not aware of this. If they compare estimated costs, they could save thousands of dollars each year in drug costs. This could make a huge impact for patients with," said lead study author Benjamin Pockros, M.D., M.B.A., a urology resident at Michigan Medicine.
Out-of-pocket costs for abiraterone prescriptions ranged from $1,379 to $13,274 among all Part D plans. The median potential cost savings among all 12 cities was $9,321.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Lions urge men to get their prostate tested at Bridgnorth eventA prostate cancer screening event that has seen more than 500 men diagnosed with the disease since it began will be returning to Bridgnorth this month.
Consulte Mais informação »
Krispy Kreme launches three doughnuts to celebrate 20th birthdayThe doughnuts have been created with the help of Krispy Kreme fans online
Consulte Mais informação »
Men with sneaky testosterone physiology have worse prostate cancer outcomes, study findsFirst-of-its-kind study on 266 men found 20% have higher levels of the hormone in the vessels surrounding the prostate.
Consulte Mais informação »
People will have to wait years to get weight-loss drug Wegovy on the NHS despite UK rolloutIndustry experts believe ongoing supply constraints of Wegovy mean the drug will only initially be available on the NHS for morbidly obese patients - those with a BMI of at least 35
Consulte Mais informação »
Did COVID-19 mortality differ between patients with cancer and the general US population depending on which SARS-CoV-2 variant was dominant?Researchers comparatively evaluated COVID-19 mortality among cancer patients during different periods of the SARS-CoV-2 outbreak.
Consulte Mais informação »
Measuring children's looking behavior yields new tool to help diagnose autism earlierResults of clinical studies published simultaneously in the Journal of the American Medical Association (JAMA) and in JAMA Network Open demonstrate that measuring children's looking behavior predicts expert clinical diagnosis of autism in children between ages 16 to 30 months tested with a high degree of accuracy.
Consulte Mais informação »